Clinical trials
Phase 3 Pneumonia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 9 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Terminated | 12 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 5 |
| Melinta Therapeutics, Inc. | 3 |
| Vaxcyte, Inc. | 3 |
| Advanced Life Sciences, Inc. | 2 |
| Nabriva Therapeutics AG | 2 |
| Novartis Pharmaceuticals | 2 |
| Polyphor Ltd. | 2 |
| Abbott Nutrition | 1 |
| Albany Medical College | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pneumonia | 46 |
| COVID-19 | 13 |
| Pneumonia, Viral | 6 |
| Coronavirus Infections | 5 |
| Infections | 5 |
| Lung Diseases | 5 |
| Respiratory Tract Infections | 5 |
| Community-Acquired Pneumonia | 4 |
| Cytokine Release Syndrome | 4 |
| Respiratory Distress Syndrome | 4 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.